57|10000|Public
60|$|As Mr. Perrott {{proceeded}} <b>to</b> <b>deliver</b> <b>an</b> <b>opinion,</b> and Evelyn {{insisted that}} he was much too stingy, like all lawyers, thinking of the letter and not of the spirit, while Mrs. Paley required to be kept informed between the courses {{as to what they}} were all saying, the luncheon passed with no interval of silence, and Arthur congratulated himself upon the tact with which the discussion had been smoothed over.|$|E
60|$|<b>To</b> <b>deliver</b> <b>an</b> <b>opinion</b> is {{the right}} of all men; that of {{constituents}} is a weighty and respectable opinion, which a representative ought always to rejoice to hear, and which he ought always most seriously to consider. But authoritative instructions, mandates issued, which the member is bound blindly and implicitly to obey, to vote, and to argue for, though contrary to the clearest conviction of his judgment and conscience,--these are things utterly unknown {{to the laws of}} this land, and which arise from a fundamental mistake of the whole order and tenor of our Constitution.|$|E
60|$|For a {{week the}} boat was carried over the sea by a fresh, steady breeze, during which time the sun shone out frequently, so that things seemed not so wretched as one might suppose to the shipwrecked mariners. Of course the poor cabin-boy was an exception. Although his feverish attack was a slight one he felt very weak and miserable after it. His {{appetite}} began to return, however, and {{it was evident that}} the short daily allowance would be insufficient for him. When this point was reached Dick Darvall one day, when rations were being served out, ventured <b>to</b> <b>deliver</b> <b>an</b> <b>opinion.</b>|$|E
50|$|The Committee of Ministers may, by {{majority}} vote, ask the Court <b>to</b> <b>deliver</b> <b>an</b> advisory <b>opinion</b> on {{the interpretation}} of the European Convention on Human Rights, unless the matter relates to the content and scope of fundamental rights which the Court already considers.|$|R
5000|$|In 2015, Iain Duncan Smith {{complained that}} the system gave doctors a [...] "binary choice", not <b>an</b> {{opportunity}} <b>to</b> <b>deliver</b> <b>a</b> more nuanced <b>opinion</b> on claimants' fitness for work.|$|R
40|$|Following {{a request}} from the Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on the safety in use of rosemary extracts when used as an antioxidant. Rosemary extracts are derived from Rosmarinus officinalis L. and contain several compounds which have been proven to exert antioxidative functions. These compounds belong mainly to the classes of phenolic acids, flavonoids, diterpenoids and triterpenes. The present opinion refers to rosemary extracts prepared using several solvent extraction techniques. These will be named by the acronyms provided by the petitioner and are as follows: F 62 : rosemary extract produced from dried rosemary leaves by acetone extraction...|$|R
50|$|The Standard Ethics Rating is a Solicited Sustainability Rating (SSR). It is {{a rating}} that intends <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> {{on the level}} of {{compliance}} by companies and sovereign nations in the field of sustainability and corporate social responsibility (CSR) on the basis of documents and guidelines published by the United Nations (UN), the Organisation for Economic Co-operation and Development (OECD), The European Union (EU).The methodological approach of Standard Ethics dates back to 2001, as a research department of the Agenzia Europea d’Investimenti (AEI) SpA, an Italian holding company active in the sustainable investments. It becomes a separate entity after a spin-off in 2003.|$|E
40|$|Food Safety and Nutrition Department {{received}} a request of scientists from national scientific group on Animal Health and Welfare and Biological Hazards to prepare opinion on risk assessment of Anthrax in the Slovak Republic. The {{aim of this}} request is <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> about the last case of Anthrax in Slovakia, which was in 2010, the principles of caution and warning, {{with a focus on}} possible risk factors. The request was approved by Food Safety and Nutrition Committee...|$|E
40|$|Visual {{illustration}} {{does not}} only cover the aesthetical function, {{but it also}} becomes the main part to present visual opinion. Illustration has an ability to deliver something that not only {{can be seen on}} the surface; furthermore, it has deeper meaning than written language without to be explicit. This paper begins with a brief explanation about illustration and its visual language. Then it describes the various approaches in conveying the message and its application in illustrations. The research method used in this paper is literature study, followed by a reflective analysis of the data. At the end, article reveals a clearer picture of how ideas conveyed through visual language and its relation <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> in a visual form.  </p...|$|E
40|$|The PPR Panel {{was asked}} <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> {{on the science}} behind {{the development of a}} risk assessment of plant protection products on bees (Apis mellifera, Bombus spp. and solitary bees). Specific protection goals options were suggested based on the ecosystem services approach. The different routes of exposure were analysed in detail for different categories of bees. The existing test guidelines were evaluated and suggestions for improvement and further research needs were listed. A simple prioritisation tool to assess cumulative effects of single pesticides using mortality data is suggested. Effects from repeated and simultanous exposure and synergism are discussed. Proposals for separate risk assessment schemes, one for honey bees and one for bumble bees and solitary bees, were developed...|$|R
40|$|Following {{a request}} from the Health and Consumer Protection, Directorate General, European Commission, the Panel on Biological Hazards was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on “The use and mode of action of bacteriophages in food production”. In accordance with the terms of reference, this report does not consider the safety assessment {{of the use of}} bacteriophages on foods. Modern microbial food safety assurance is based on a farm-to-fork principle that involves a wide range of coordinated control measures applied at all relevant steps in the food chain. A large number of different food decontamination treatments have been described in the literature. Some of them involve the application of live microorganisms to inhibit or eradicate pathogenic and/or spoilage bacteria in/on foods. To this regard, the use of bacteriophages has recently attracted a growing interest. This Opinion deals only with bacteriophage-base...|$|R
40|$|Following {{a request}} from the European Commission, the Panel on Plant Protection Products and their Residues (PPR) was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on {{the report of the}} FOCUS groundwater working group (FOCUS, 2009) with respect to lower tier leaching assessments. The PPR Panel is of the general opinion that the FOCUS groundwater working group has successfully harmonised major concepts in the leaching models and that, overall, the leaching estimations have improved. Despite several limitations, the PPR Panel considers that the revised FOCUS scenarios cover significant arable areas in the EU, including the New Member States, and allow for decision making at the EU level. The PPR Panel however has observed that flaws in underlying data have become apparent after finalising the report. Also new approaches on scenario selection have become available. The PPR Panel recommends that these flaws and new approaches are taken into account when developing revised scenarios...|$|R
40|$|Following an {{application}} from Nutrilinks Sarl submitted for authorisation {{of a health}} claim pursuant to Article 13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of Cyprus, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation of a health claim related to ♀EFAX™ and reduction of menstrual discomfort. The food, ♀EFAX™, which is standardised pure krill oil and {{is the subject of}} the health claim, is sufficiently characterised. The claimed effect, reduction of menstrual discomfort, is a beneficial physiological effect. No human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. A cause and effect relationship has not been established between the consumption of ♀EFAX™ and reduction of menstrual discomfort...|$|E
40|$|Following an {{application}} from ICP Ltd, submitted for authorisation {{of a health}} claim pursuant to Article  13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of Malta, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation of a health claim related to Preservationc and “rapid recovery of cellular activity post stress”. The Panel considers that Preservation®, which contains an extract of prickly pear cactus Opuntia ficus-indica, is sufficiently characterised. The claimed effect is “rapid recovery of cellular activity post stress”. The claimed effect is general and non-specific, and the references provided did not provide information {{which could be used}} to define a specific beneficial physiological effect. The Panel considers that the claimed effect is general and non-specific, and does not comply with the criteria laid down in Regulation (EC) No 1924 / 2006...|$|E
40|$|Following an {{application}} from Kemin Foods LC, submitted for authorisation {{of a health}} claim pursuant to Article 13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of Belgium, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation of a health claim related to Slendesta® Potato Extract and reduction of body weight. The food constituent, Slendesta® Potato Extract, {{that is the subject}} of the health claim is sufficiently characterised. The claimed effect, a reduction of body weight, is a beneficial physiological effect for overweight individuals. In weighing the evidence, the Panel took into account that all four human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim did not show an effect of Slendesta® Potato Extract on the reduction of body weight. The Panel concludes that a cause and effect relationship has not been established between the consumption of Slendesta® Potato Extract and reduction of body weight...|$|E
40|$|Following {{a request}} from the European Commission, the Panel on Plant Protection Products and their Residues (PPR) was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on {{the report of the}} FOCUS groundwater working group (FOCUS, 2009) with respect to the higher tier leaching assessments. The PPR Panel is of the general opinion that, as suggested in the FOCUS report, substance parameter refinement can be applied in risk assessment. State of the art knowledge has developed {{to such an extent that}} scenario refinement is feasible as well, but will make assessment more complex unless embedded in basic tools and adequate guidance. The same is true for spatial modelling but establishment of adequate databases will require quite some effort. The Panel considers current knowledge on groundwater hydrology insufficient for implementation of monitoring as the highest tier of the assessment at the European level. The implementation of scenario refinement and spatial modelling requires clear criteria on the extent of arable surface areas with estimated leaching rates below the threshold level...|$|R
40|$|Following {{a request}} from the European Commission, the EFSA Panel on Plant Health (PLH Panel) has been asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on the risks posed by Daktulosphaira vitifoliae for the European Union (EU) and to identify and evaluate risk management options for this pest. In particular, the PLH Panel was asked to provide <b>an</b> <b>opinion</b> {{on the effectiveness of}} the current EU requirements against this organism. The PLH Panel created a working group to respond to this request by the end of May 2014. The activity will be conducted in accordance with methodologies developed by the PLH Panel and follow International Plant Protection Convention standards. Since this mandate is the first received by the PLH Panel on an important pest of Vitis sp., the first step will be to identify information gaps and additional expertise which the group might need. A major task of the working group will be to try to determine whether there are aggressive strains of D. vitifoliae outside or inside the EU territory which might pose a risk to EU grapevines...|$|R
40|$|Following {{a request}} from the European Commission, the Panel on Animal Health and Welfare was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on welfare aspect of the main systems of stunning and killing of farmed Atlantic salmon (Salmo salar) in the EU. Harvesting and processing of farmed Atlantic salmon {{are the same as}} for sea-farmed rainbow trout (Oncorhynchus mykiss); therefore this scientific opinion and its conclusions can also be applied to the sea farmed trout 1 production. A semi-quantitative risk assessment approach was used to rank the risks of poor welfare associated with the different commercially applied stunning and killing methods for Atlantic salmon. The risk assessment was also used to identify other areas of concern, as well as to provide guidance for future research. The risk assessment was mainly based on expert opinion, due to the limited amount of quantitative data and published peer-reviewed data on many effects of hazards associated with killing of Atlantic salmon. Pre-slaughter stages which have a direct impact on the welfare immediately before and during killing wer...|$|R
40|$|Following an {{application}} from Nutrilinks Sarl, submitted pursuant to Article 13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of Cyprus, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation {{of a health}} claim related {{to a combination of}} Paullinia cupana Kunth (guarana) and Camellia sinensis (L.) Kuntze (green tea) extracts and reduction of body weight. The Panel considers that the food constituent which is the subject of the health claim is sufficiently characterised. The claimed effect, reduction of body weight, is a beneficial physiological effect for overweight subjects. One human intervention study from which no conclusions could be drawn for the scientific substantiation of the claim was provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of Paullinia cupana Kunth (guarana) and Camellia sinensis (L.) Kuntze (green tea) extracts and a reduction in body weight...|$|E
40|$|Following an {{application}} from Omikron Italia S. r. l., submitted pursuant to Article 13. 5 of Regulation (EC) No 1924 / 2006 via the Competent Authority of Italy, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation {{of a health}} claim related {{to a combination of}} diosmin, troxerutin and hesperidin and maintenance of normal venous tone. The food that is a subject of the health claim, a combination of diosmin, troxerutin and hesperidin, is sufficiently characterised. The claimed effect, maintenance of normal venous tone, is a beneficial physiological effect. No human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of diosmin, troxerutin and hesperidin and the maintenance of normal venous tone...|$|E
40|$|Following an {{application}} from Clasado Limited, submitted for authorisation {{of a health}} claim pursuant to Article  13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of Malta, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation of a health claim related to Bimuno® GOS and reducing gastro-intestinal discomfort. The food constituent, Bimuno® GOS, a mixture of β-galacto-oligosaccharides, which {{is the subject of}} the health claim, is sufficiently characterised. The claimed effect proposed by the applicant is “reduce bloating, flatulence and abdominal pain. These effects can be described collectively as abdominal discomfort” and the target population proposed by the applicant is the general adult population. Reducing gastro-intestinal discomfort is a beneficial physiological effect. A health claim on Bimuno® GOS and reducing gastro-intestinal discomfort has already been assessed by the Panel with an unfavourable outcome. The supplementary information submitted by the applicant in this application did not provide evidence {{that could be used for}} the scientific substantiation of this claim...|$|E
40|$|Following {{a request}} from the European Commission, the Panel on Plant Protection Products and their Residues (PPR Panel) was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on the toxicological relevance of 2 -trifluoromethyl-benzene-sulfonamide (TBSA), a soil and ground water metabolite of tritosulfuron, {{in the context of}} its potential risk to humans. Tritosulfuron is a new active substance submitted for registration in Europe for use as a post emergence systemic herbicide to control a range of dicotyledonous weeds in cereals. TBSA was identified in lysimeter studies at a concentration of 0. 107 µg/L in groundwater. TBSA has been identified as a minor metabolite (< 1 % of the administered dose) in the rat after single or repeated administration of [phenyl- 14 C]-tritosulfuron. Furthermore, TBSA has been identified in batches of technical grade tritosulfuron as an impurity. Several toxicity studies have been performed on TBSA but concerns regarding the chromosomal damaging (clastogenic) properties and the potential reproductive toxicity of the compound remained. The following questions were posed: i) based on the available data, does the PPR Pane...|$|R
40|$|Following {{a request}} from the Health and Consumer Protection, Directorate General, European Commission, the Panel on Biological Hazards was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on Microbiological Risk Assessment in feedingstuffs for food-producing animals for both public health and animal health. In accordance with the terms of reference, this report does not consider hazards such as BSE/TSE agents, parasites and virus, or contamination by fungi and mycotoxins. The Panel on Biological Hazards identified Salmonella spp. as the major hazard for microbial contamination of animal feed. Listeria monocytogenes, Escherichia coli O 157 : H 7 and Clostridium sp. are other hazards for which feed is regarded a far less important source. In addition, antimicrobial resistant bacteria, or antimicrobial resistance genes can be transmitted via feed. Forage, industrial compound feed, home-grown cereals and purchased straight feedingstuff are the four major groups of feeds for EU livestock. The report focuses on industrial compound feed as the feed group with the highest risk for becoming contaminated by Salmonella spp. Oil seed meal and animal derived protein are the major risk feed materials for introducin...|$|R
40|$|The European Food Safety Authority (EFSA) asked its Panel on Biological Hazards <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on: The {{assessment of}} the Public Health significance of meticillin resistant Staphylococcus aureus (MRSA). There are different states of interaction between S. aureus and its host: infections, carriage or colonisation, and contamination. Meticillin resistant S. aureus (MRSA) can be persistently or intermittently carried by healthy humans, and colonisation is the major risk factor for infection. Infection can be mild to severe and, in some instances, fatal. MRSA are now {{a major cause of}} hospital acquired infection in many European countries, with large differences in prevalence and control policies. A limited number of lineages of MRSA tend to predominate in specific geographical locations. CC 398 is the MRSA lineage most often associated with asymptomatic carriage in intensively reared food-producing animals. MRSA commonly carry enterotoxin genes but there has been only one report of food intoxication due to MRSA. On the question on what is the risk to human health posed by MRSA associated with food-producing animals, the Panel concluded that...|$|R
40|$|Following an {{application}} from IDACE, submitted pursuant to Article 14 of Regulation (EC) No 1924 / 2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation {{of a health}} claim related to iron and contribution to normal cognitive development. The food constituent, iron, which {{is the subject of}} the health claim, is sufficiently characterised. Contribution to normal cognitive development is a beneficial physiological effect for infants and young children. A claim on iron and cognitive development in children (up to 18 years) has already been assessed with a favourable outcome. The Panel notes that the role of iron in normal cognitive development also applies to infants and young children (from birth to three years). The Panel concludes that a cause and effect relationship has been established between dietary intake of iron and contribution to normal cognitive development. The following wording reflects the scientific evidence: “Iron contributes to normal cognitive development”. The target population is infants and children up to three years...|$|E
40|$|Following an {{application}} from Leiber GmbH, submitted for authorisation {{of a health}} claim pursuant to Article 13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of Germany, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation of a health claim related to Yestimun® and defence against pathogens in the upper respiratory tract. The food {{that is the subject}} of the health claim, Yestimun®, which consists of (1, 3) -(1, 6) -β-D-glucans from brewer’s yeast cell wall, is sufficiently characterised. The claimed effect, defence against pathogens in the upper respiratory tract, is a beneficial physiological effect. No human intervention studies from which conclusions could be drawn for the scientific substantiation of the claim were provided by the applicant. The Panel concludes that a cause and effect relationship has not been established between the consumption of Yestimun® ((1, 3) -(1, 6) -β-D-glucans from brewer’s yeast cell wall) and defence against pathogens in the upper respiratory tract...|$|E
40|$|Following an {{application}} from S. A. Vichy Catalan, submitted for authorisation {{of a health}} claim pursuant to Article 13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of Spain, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation of a health claim related to Vichy Catalan carbonated natural mineral water and reduction of post-prandial lipaemic response. The food, Vichy Catalan carbonated natural mineral water, {{that is the subject}} of the health claim is sufficiently characterised. The claimed effect, reduction of post-prandial lipaemic response, is a beneficial physiological effect. In weighing the evidence, the Panel took into account that the results of the only study from which conclusions could be drawn for the scientific substantiation of the claim do not support an effect of Vichy Catalan carbonated natural mineral water on the reduction of post-prandial lipaemic response. A cause and effect relationship has not been established between the consumption of Vichy Catalan carbonated natural mineral water and reduction of post-prandial lipaemic response...|$|E
40|$|Following {{a request}} from the Spanish Competent Authority, the EFSA Scientific Panel on Biological Hazards (BIOHAZ) was asked <b>to</b> <b>deliver</b> <b>a</b> Scientific <b>Opinion</b> on the {{biological}} safety of a specific process for the Hydrolysis on-Farm of Dead Pigs. The application concerns the on-farm treatment of pig carcasses and other pig by-products 2, which are considered as Category 2 animal by-products according to Reg. (EC) No 1774 / 2002, through an enzymatic hydrolysis in mesophilic and partially anaerobic conditions within a closed vat {{for a period of}} minimum six months. The intended end-use of the processed material is represented by its utilisation as organic fertilizer or soil improver, as composting material, as biogas production material or as <b>a</b> material <b>to</b> be <b>delivered</b> <b>to</b> <b>a</b> waste management unit for disposal. The BIOHAZ Panel concluded that, due to some deficiencies in the provided dossier, {{it was not possible to}} assess the safety of the process for the disposal or use of Category 2 animal by-products. The BIOHAZ Panel does not recommend this process to be applied as an alternative method of disposal or use of Category 2 animal by-products...|$|R
60|$|On this solemn {{judgment}} {{concerning the}} law and usage of Parliament, {{it is to be}} remarked: First, that the impeachment itself is not to be presumed inartificially drawn. It appears to have been the work of some of the greatest lawyers of the time, who were perfectly versed in the manner of pleading in the courts below, and would naturally have imitated their course, if they had not been justly fearful of setting an example which might hereafter subject the plainness and simplicity of a Parliamentary proceeding to the technical subtilties of the inferior courts. Secondly, that the question put to the Judges, and their answer, were strictly confined to {{the law and}} practice below; and that nothing in either had <b>a</b> tendency <b>to</b> their <b>delivering</b> <b>an</b> <b>opinion</b> concerning Parliament, its laws, its usages, its course of proceeding, or its powers. Thirdly, that the motion in arrest of judgment, grounded on the opinion of the Judges, was made only by Dr. Sacheverell himself, and not by his counsel, men of great skill and learning, who, if they thought the objections had any weight, would undoubtedly have made and argued them.|$|R
40|$|Following {{a request}} from the Commission, the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on the safety in use of synthetic lycopene as a food colour {{for use in the}} food categories specified in the dossier. The Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food has also been asked to evaluate the safety in use of lycopene from Blakeslea trispora as a food colour in the food categories and use levels as proposed in the dossier. In addition, in view of the re-evaluation of lycopene from tomatoes within the re-evaluation programme of all food colours, the Panel decided to make a global safety assessment of lycopene from all sources. Thus, in the present opinion the Panel evaluates the safety in use of lycopene from different sources as a food colour. Results from animal and human intervention studies with synthetic lycopene or tomato extract as lycopene source indicate that lycopene from these sources is bioavailable. It is expected that lycopene from B. trispora when used in foodstuffs of comparable composition will be bioavailable to a similar extent as lycopene from tomatoes...|$|R
40|$|Following an {{application}} from Vivatech, submitted for authorisation {{of a health}} claim pursuant to Article 13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation of a health claim related to Transitech® and improvement of bowel function which is maintained after cessation of consumption of the food. The food, Transitech®, {{that is the subject}} of the health claim is sufficiently characterised. The claimed effect, improvement of bowel function which is maintained after cessation of consumption of the food, is a beneficial physiological effect. In weighing the evidence, the Panel considered that the one study that investigated the claimed effect did not show an effect of Transitech® on bowel function which is maintained after cessation of consumption of the food. A cause and effect relationship has not been established between the consumption of Transitech® and improvement of bowel function which is maintained after cessation of consumption of the food...|$|E
40|$|Products, Nutrition and Allergies {{was asked}} <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the {{scientific}} substantiation {{of a health}} claim related to Efalex ® and learning ability. The scope of the application was proposed to fall under a health claim referring to children’s development and health. The food for which the claim made is Efalex ® products, which contain {{a combination of the}} n- 3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n- 6 PUFAs gamma-linolenic acid (GLA) and arachidonic acid (ARA). The Panel notes that the complete fatty acid spectra of Efalex ® products are not reported. The Panel considers that the food for which the claim is made (i. e., Efalex ® products) is sufficiently characterised regarding the content of DHA, EPA, GLA and ARA. The claimed effect is to “help maintain learning ability”. The target population is children between 2 and 18 years of age. The Panel considers that supporting learning ability is beneficial to children’s development and health. The applicant identified a total of 56 publications as being pertinent to the health claim. Thes...|$|E
40|$|Following an {{application}} from Marks and Spencer PLC, submitted for authorisation {{of a health}} claim pursuant to Article 13 (5) of Regulation (EC) No 1924 / 2006 via the Competent Authority of the United Kingdom, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked <b>to</b> <b>deliver</b> <b>an</b> <b>opinion</b> on the scientific substantiation of a health claim related to a CHO:P ratio = 3. 0 on overweight and obese adults {{in the context of}} energy restriction. Four out of seven studies lasting < 12 weeks reported an effect of a CHO: P ratio <= 1. 8 on body weight in overweight/obese subjects, whereas no significant effect was observed in six out of the seven studies lasting 12 weeks or more. The Panel considers that these studies do not provide evidence for a sustained effect of the food/constituent on body weight. The Panel concludes that a cause and effect relationship has not been established between the consumption of a fixed CHO: P ratio <= 1. 8 on an energy basis consumed {{in the context of an}} energy-restricted diet and reduction of body weight. (C) 2017 European Food Safety Authority...|$|E
40|$|Following {{a request}} from the Commission, the Panel on Plant Protection Products and their Residues (PPR) was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on the possible developmental neurotoxicity of deltamethrin. The potential developmental neurotoxicity of deltamethrin was addressed by the notifier in guideline-compliant reproductive and developmental toxicity studies in different animal species including a multi-generation study in rats and a separate developmental neurotoxicity (DNT) study in the rat, {{in accordance with the}} new OECD guideline TG 426. The data available from the open literature include experimental studies carried out in rodents involving exposure during prenatal life and/or during neonatal life. These studies had several limitations and did not provide any clear evidence for a developmental neurotoxic effect of deltamethrin. The PPR Panel concluded that deltamethrin has been adequately tested for developmental neurotoxicity and that the available data do not indicate that deltamethrin is a developmental neurotoxic agent. The existing health-based guidance values for deltamethrin are based on neurological signs, as the most relevant critical effects observed in adult animals from different species. The lowest NOAEL of 1 mg/kg bw/day, used for risk assessment, was obtained in the 90 -day and 1 -year dog studies for which a 100 -fol...|$|R
40|$|Following {{a request}} from the European Commission, the European Food Safety Authority was asked <b>to</b> <b>deliver</b> <b>a</b> {{scientific}} <b>opinion</b> on the proposal for reducing the withdrawal period from three days to one day and the setting of a final maximum residue limit (MRL) for the product Coxidin ® for chickens and turkeys for fattening. No data which would allow proposing a final MRL for monensin in poultry tissues was provided. A number of monensin metabolites (M 1, M 2, M 5, M 6) were isolated and tested for their biological activities. All monensin metabolites tested appeared to show lower ionophoric activity than the parent compound. These findings confirm the results of earlier studies. Comparable results on reduced ionophoric activity of metabolites from a related polyether antibiotic support the above findings on monensin. Non-extractable residues in chicken liver and kidney after a one-day withdrawal period amount to more than 50 % of the total residues. About 90 % of total radioactivity {{was associated with the}} abdominal fat in chicken for fattening. In milk, about 25 % of the total residues are attributed to fatty acids. The Panel on Additives and Products or Substances used in Anima...|$|R
40|$|Following {{a request}} from the European Commission, the Panel on Additives and Products or {{substances}} used in Animal Feed (FEEDAP) was asked <b>to</b> <b>deliver</b> <b>a</b> scientific <b>opinion</b> on the compatibility of microbial feed additive Bacillus subtilis PB 6 with the coccidiostats maduramycin ammonium, monensin sodium, narasin and robenidine hydrochloride. The in vivo compatibility of the coccidiostats with Bacillus subtilis PB 6 was assessed {{as part of a}} larger trial in which performance characteristics were measured. A negative control group was included, while the other groups received the recommended dose of Bacillus subtilis PB 6 in the presence or absence of the tested coccidiostats at their maximum authorised levels. Intestinal samples from six birds per treatment group were analysed for aerobic spore formers. Heat treatment of the samples was included to distinguish spores from vegetative cells. No significant differences in numbers of bacilli were observed between the coccidiostat-treated groups and the group treated with Bacillus subtilis PB 6 alone. Consequently, the FEEDAP Panel concludes that Bacillus subtilis PB 6 is compatible with maduramycin ammonium, monensin sodium, narasin and robenidine hydrochloride when added to diets for chickens for fattening...|$|R
